LGND Sale Disclosure
Aryeh Jason · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$15.91K
Aryeh Jason Director
LGND
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
LGND daily price context
Close on/before transaction
$322.75
Oct 30, 2026
First close after public filing
$316.13
Nov 4, 2026
Return after filing · so far
-3.14%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 50 shares @ $318.23
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001376960-26-000005
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$676.16K
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Sale | Nov 2, 2026 | $224.3K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 30, 2026 | $387.38K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 30, 2026 | $16.65K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 30, 2026 | $16.02K |
| Ligand Pharmaceuticals Inc LGND | Sale | Oct 30, 2026 | $15.89K |
| Ligand Pharmaceuticals Inc LGND Current | Sale | Oct 30, 2026 | $15.91K |